South Africa's State-owned nuclear energy firm, NECSA, has launched a tender to replace its ageing nuclear research reactor, Safari 1, and help maintain its position as one of the world's top producers of Molybdenum-99 used in medical diagnostic imaging.
Molybdenum-99, or Mo-99, is used in millions of diagnostic tests for cancer, heart disease and other illnesses worldwide.